Bicara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	462.07	489.71	230.44	4.16
Cash & Short-Term Investments	462.07	489.71	230.44	4.16
Cash Growth	100.51%	112.51%	5442.09%	-
Receivables	-	-	0.1	0.07
Prepaid Expenses	8.69	12.82	0.53	0.76
Total Current Assets	470.75	502.53	231.07	4.98
Property, Plant & Equipment	0.69	0.85	0.82	0.64
Other Long-Term Assets	6.64	6.62	1.99	0.94
Total Assets	478.08	510	233.98	6.7
Accounts Payable	2.74	4.51	3.19	5.14
Accrued Expenses	15.79	12.88	11.61	18.76
Current Portion of Leases	0.59	0.61	0.29	-
Total Current Liabilities	19.12	17.99	15.09	23.9
Long-Term Leases	-	0.13	0.37	-
Other Long-Term Liabilities	-	-	0.02	0.09
Total Liabilities	19.12	18.12	15.47	23.98
Common Stock	0.01	0.01	0	0
Additional Paid-In Capital	716.81	712.88	4.25	2.23
Retained Earnings	-257.86	-221.02	-153.02	-101.04
Total Common Equity	458.96	491.88	-148.77	-98.8
Shareholders' Equity	458.96	491.88	218.51	-17.28
Total Liabilities & Equity	478.08	510	233.98	6.7
Total Debt	0.59	0.74	0.66	-
Net Cash (Debt)	461.47	488.97	229.78	4.16
Net Cash Growth	100.83%	112.80%	5426.29%	-
Net Cash Per Share	15.25	29.10	396.10	9.69
Filing Date Shares Outstanding	54.54	54.52	34.26	0.43
Total Common Shares Outstanding	54.53	54.44	0.64	0.43
Working Capital	451.63	484.54	215.99	-18.91
Book Value Per Share	8.42	9.04	-232.15	-230.26
Tangible Book Value	458.96	491.88	-148.77	-98.8
Tangible Book Value Per Share	8.42	9.04	-232.15	-230.26

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q